1. Chemotherapy in acute myelogenous leukemia: high dose, higher expectations;Berman;J. Clin. Oncol.,1995
2. What is the best induction regimen for acute myelogenous leukemia;Rowe;Leukemia,1998
3. Current situation and perspective for treatment of acute myelogenous leukemia in adults;Fukushima;Jpn. J. Cancer Chemother.,1998
4. Metabolism and selective effects of 1-β-D-arabino-furanosylcytosine in L1210 and host tissuesin vivo;Chou;Cancer Res.,1975
5. The effect of 1-β-D-arabinofuranosylcytosine ongrowth, viability, and DNA synthesis of mouse L-cells;Graham;Cancer Res.,1970